- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Nodal Marginal Zone B-cell Lymphoma in United States
Total 2615 results
-
Janssen Research & Development, LLCTerminatedLymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Mantle-CellUnited States, Australia, France, Belgium, Turkey, Netherlands, Korea, Republic of
-
PfizerIncyte Corporation; MorphoSys AGRecruitingDiffuse Large B-Cell LymphomaUnited States, Japan, Puerto Rico, Korea, Republic of
-
CelgeneCompletedLymphoma, Large B-Cell, DiffuseUnited States, Austria, United Kingdom, Estonia, Denmark
-
Hoffmann-La RocheGenentech, Inc.TerminatedB-cell LymphomaItaly, China, United States, New Zealand, Canada, Australia, Austria, France, Spain, United Kingdom, Brazil, Colombia, Russian Federation, Thailand, Germany, Panama, Peru, Korea, Republic of, Hong Kong, Sweden, Argentina, Ecuador, P... and more
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...CompletedRecurrent Hodgkin Lymphoma | Recurrent Adult Acute Myeloid Leukemia | Recurrent Mantle Cell Lymphoma | Waldenstrom Macroglobulinemia | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood... and other conditionsUnited States
-
Hoffmann-La RocheCompleted
-
Memorial Sloan Kettering Cancer CenterRecruitingLymphoma | Lymphoma, B-Cell | Multiple Myeloma | High-grade B-cell Lymphoma | Refractory B-Cell Lymphoma | DLBCL NOSUnited States
-
Spectrum Pharmaceuticals, IncCompletedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Recurrent Hodgkin Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Childhood Acute Lymphoblastic Leukemia | Plasma Cell Myeloma | Recurrent Diffuse Large B-Cell Lymphoma | Prolymphocytic Leukemia | Refractory Chronic... and other conditionsUnited States, Denmark
-
Karyopharm Therapeutics IncRecruitingRelapsed/Refractory Diffuse Large B-cell LymphomaUnited States, Spain, Israel, Italy, Poland, China, Austria
-
Affimed GmbHTerminatedRefractory B-Cell Non-Hodgkin Lymphoma | Relapsed B-Cell Non-Hodgkin LymphomaUnited States, Czechia, Germany, Poland
-
GenmabAbbVieActive, not recruitingDiffuse Large B-cell LymphomaKorea, Republic of, Spain, Taiwan, Belgium, France, Israel, United Kingdom, China, United States, Netherlands, Japan, Sweden, Turkey, Australia, Singapore, Germany, Denmark, Poland, Italy, Hungary, Austria, Russian Federation, Norway, Canad... and more
-
Genzyme, a Sanofi CompanyCompletedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)United States
-
Curis, Inc.CompletedRelapsed and/or Refractory Diffuse Large B-cell Lymphoma Including With Myc AlterationsUnited States, Spain
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Immunoblastic Large Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Adult Acute Lymphoblastic Leukemia | Refractory Chronic Lymphocytic Leukemia | Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia and other conditionsUnited States
-
Spectrum Pharmaceuticals, IncTerminatedDiffuse Large B-cell Lymphoma | Follicle Center LymphomaUnited States, France, United Kingdom, Ireland, Israel, Belgium, Spain, Netherlands, Australia, Puerto Rico, Canada, Italy, Austria
-
AstraZenecaCompletedDiffuse Large B-Cell LymphomaUnited States, United Kingdom
-
TG Therapeutics, Inc.SCRI Development Innovations, LLCCompletedHodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Peripheral T-Cell LymphomaUnited States
-
Kite, A Gilead CompanyPfizerTerminatedRelapsed/Refractory Large B-cell LymphomaUnited States
-
BayerCompletedDiffuse, Large B-Cell, LymphomaBelgium, France, Canada, Korea, Republic of, Australia, Germany, United Kingdom, Italy, Denmark, Singapore
-
Karyopharm Therapeutics IncSuspendedRelapsed or Refractory Diffuse Large B-Cell LymphomaUnited States
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedChronic Lymphocytic Leukaemia (CLL) | Multiple Myeloma (MM) | B-Cell Non-Hodgkin Lymphoma (NHL)France, Australia, Germany, Korea, Republic of, United Kingdom, Hungary, Poland, Singapore
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia | Primary Myelofibrosis | Thrombocytopenia | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Venous Thromboembolism | Myelodysplastic Syndrome | B-Cell Non-Hodgkin Lymphoma | Hematopoietic Cell Transplantation Recipient | Chronic Myelogenous Leukemia, BCR-ABL1 Positive and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic Lymphoma | Recurrent B-Cell Prolymphocytic Leukemia | Refractory B-Cell Prolymphocytic LeukemiaUnited States
-
Georg Aue, M.D.National Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic LymphomaUnited States
-
PfizerHoffmann-La RocheRecruitingDiffuse Large B-Cell LymphomaUnited States, Taiwan, Japan, Israel
-
Hoffmann-La RocheCompletedLymphoma, Large B-Cell, DiffuseUnited States, France, Spain, Italy
-
Sunesis PharmaceuticalsCompletedMultiple Myeloma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | B-lymphoid MalignanciesUnited States
-
PeproMene Bio, Inc.City of Hope Medical CenterRecruitingRelapsed or Refractory B-cell Non-Hodgkin's LymphomaUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedDiffuse Large B Cell Non-Hodgkin LymphomaUnited States
-
Novartis PharmaceuticalsCompletedCD79 Mutant or ABC-subtype Diffuse Large B-Cell LymphomaTaiwan, Italy, Netherlands, Hong Kong, Germany, United States, Korea, Republic of, France
-
MorphoSys AGActive, not recruitingDiffuse Large B Cell LymphomaSpain, Czechia, Korea, Republic of, Israel, Poland, Italy, Austria, France, United States
-
Bristol-Myers SquibbCompletedLymphoma. Non-HodgkinGermany, Italy, United States, Spain, Netherlands, Australia, United Kingdom, Belgium, France, Canada, Sweden, Singapore
-
Cancer Research UKBioInvent International AB; BloodwiseCompletedB-cell Lymphoma | Waldenström Macroglobulinemia | Chronic Lymphocytic LeukaemiaUnited Kingdom
-
Alopexx Oncology, LLCTerminatedB-cell Non-Hodgkin LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedLymphoma | B-cell Non-Hodgkin's LymphomaUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)National Cancer Institute (NCI); Blood and Marrow Transplant Clinical Trials...CompletedLymphoma, Follicular | Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Acute Leukemia | Chronic Myelogenous Leukemia | Myelodysplasia | Small Lymphocytic LymphomaUnited States
-
Joshua BrodyMerck Sharp & Dohme LLCRecruitingMantle Cell Lymphoma | Chronic Lymphocytic LeukemiaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRecurrent Adult Diffuse Large Cell Lymphoma | Intraocular Lymphoma | Central Nervous System Lymphoma | B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma | Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System and other conditionsUnited States
-
University College, LondonCompletedDiffuse Large B-Cell LymphomaUnited Kingdom
-
Royal Marsden NHS Foundation TrustCelgene CorporationActive, not recruitingDiffuse Large B-Cell LymphomaUnited Kingdom
-
University Hospital Southampton NHS Foundation...AstraZenecaRecruitingDiffuse Large B Cell LymphomaUnited Kingdom
-
TG Therapeutics, Inc.CompletedMantle Cell Lymphoma | Chronic Lymphocytic LeukemiaUnited States
-
Hoffmann-La RocheCompletedLymphomaPoland, United States, Germany
-
International Extranodal Lymphoma Study Group (IELSG)Active, not recruitingDiffuse Large B-cell LymphomaNetherlands, United Kingdom, Italy, Czechia
-
Genentech, Inc.AbbVie (prior sponsor, Abbott)WithdrawnDiffuse Large B-Cell LymphomaUnited States
-
Hoffmann-La RocheActive, not recruitingDiffuse Large B-cell LymphomaUnited States, Israel, Spain, Korea, Republic of, Poland, Taiwan
-
Fred Hutchinson Cancer CenterTerminatedRecurrent Hodgkin Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Burkitt Lymphoma | Secondary Acute Myeloid Leukemia | Myelodysplastic Syndrome | Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Acute Leukemia in Remission | Acute Undifferentiated Leukemia | Acute Biphenotypic Leukemia and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Mantle Cell Lymphoma | Recurrent Non-Hodgkin LymphomaUnited States
-
Georgetown UniversityCelgene Corporation; CephalonCompletedNon-Hodgkin's Lymphoma | Chronic Lymphocytic LeukemiaUnited States